HistoSonics

About

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Plymouth,Minnesota,United States
11 - 50
http://www.histosonics.com

Highlights

Details

Last Funding Type: Convertable Note
Last Funding Money Raised: $85M
Industries: Health Care,Medical,Medical Device
Founded date: Jan 1, 2009
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: HistoSonics, Inc.

HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

10

$226.78M

HistoSonics has raised a total of $226.78M in funding over 2 rounds. Their latest funding was raised on Dec 13, 2022 from a Convertable Note round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 13, 2022	Convertable Note	$85M	5	Johnson & Johnson Innovation – JJDC	—	Detail
Dec 13, 2022	Debt Financing	$15M	1	Signature Bank	—	Detail
Jun 8, 2020	Series C	$40M	6	Yonjin Venture	—	Detail
Apr 8, 2019	Series C	$54.70M	5	Johnson & Johnson Innovation Lumira Ventures Varian	—	Detail
Jul 13, 2018	Series Unknown	$4.82M	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

3

0

HistoSonics has made 3 investments. Their most recent investment was on Jun 17, 2021, when Anduril Industries raised $450M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jun 17, 2021 Anduril Industries	Series D	$450M	Aerospace	—
Dec 31, 2019 Axiom Space	Series A	$7M	Advanced Materials	—
Jul 15, 2019 GameOn	Pre-seed	—	Blockchain	—

Investors

Number of Lead Investors

Number of Investors

11

17

HistoSonics is funded by 17 investors. Johnson & Johnson Innovation – JJDC and Signature Bank are the most recent investors.

Investor Name	Lead Investor	Funding Round
Johnson & Johnson Innovation – JJDC	Yes	Convertable Note
Signature Bank	Yes	Debt Financing
Johnson & Johnson Innovation	Yes	Series C
Lumira Ventures	—	Convertable Note
State of Wisconsin Investment Board	—	Convertable Note
Venture Investors	—	Convertable Note
Yonjin Venture	—	Convertable Note
Varian	—	Series C
Fred Moll, M.D	—	Series C
Early Stage Partners	—	Series B